NSRX Stock Analysis: Buy, Sell, or Hold?
NSRX - Nasus Pharma Ltd.
$3.46
0.06 (1.92%)
▲
5d:
+14.03%
30d:
+14.78%
90d:
+1.92%
WAIT
LOW Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Jun 24, 2026
0d
Get Alerted When NSRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: NSRX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: NSRX shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: NSRX is currently trading at $3.46, which is considered extended relative to its 30-day fair value range of $2.99 to $3.37.
Technical Outlook: Technically, NSRX is in a uptrend. Immediate support is located at $2.96, while resistance sits at $3.60.
Market Sentiment: NSRX has a weak technical setup (18/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $19.67 (+469.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NSRX is in a uptrend. Immediate support is located at $2.96, while resistance sits at $3.60.
Market Sentiment: NSRX has a weak technical setup (18/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $19.67 (+469.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.99 -
$3.37
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (18/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 469.2% below Wall St target ($19.67)
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.99 -
$3.37
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.96
Resistance Level
$3.60
Current Trend
Uptrend
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.62
Wall Street Target
$19.67
(+469.2%)
Share & Embed Analysis
Last updated: August 08, 2026 9:18 PM ET
Data refreshes hourly during market hours. Next update: 10:18 PM
Data refreshes hourly during market hours. Next update: 10:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NSRX showing a specific setup today?
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1277 | 49 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$157 | 53 HOLD |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$270 | 53 HOLD |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$234 | 53 HOLD |
|
MRK
Merck & Company Inc |
BUY
26 analysts |
$135 | 51 HOLD |